Literature DB >> 15299544

Direct phase determination by entropy maximization and likelihood ranking: status report and perspectives.

G Bricogne1.   

Abstract

A new multisolution phasing method based on entropy maximization and likelihood ranking, proposed for the specific purpose of extending probabilistic direct methods to the field of macromolecules, has been implemented in two different computer programs and applied to a wide variety of problems. The latter comprise the determination of small crystal structures from X-ray diffraction data obtained from single crystals or from powders, and from electron diffraction data partially phased by image processing of electron micrographs, the ab initio generation and ranking of phase sets for small proteins; and the improvement of poor quality phases for a larger protein at medium resolution under constraint of solvent flatness. These applications show that the primary goal of this new method - namely increasing the accuracy and sensitivity of probabilistic phase indications compared with conventional direct methods - has been achieved. The main components of the method are (1) a tree-directed search through a space of trial phase sets; (2) the saddle-point method for calculating joint probabilities of structure factors, using entropy maximization; (3) likelihood-based scores to rank trial phase sets and prune the search tree; (4) efficient schemes, based on error-correcting codes, for sampling trial phase sets; (5) a statistical analysis of the scores for automatically selecting reliable phase indications. They have been implemented to varying degrees of completeness in a computer program (BUSTER) and tested on two small structures as well as on the small protein crambin. The main obstructions to successful ab initio phasing in the latter case seem to reside in the accumulation of phase sampling errors and in the lack of a properly defined molecular envelope, both of which can be remedied within the methods proposed. A review of the Bayesian statistical theory encompassing all phasing procedures, proposed earlier as an extension of the initial theory, shows that the techniques now available in BUSTER bring closer a number of major enhancements of standard macromolecular phasing techniques, namely isomorphous replacement, molecular replacement, solvent flattening and non-crystallographic symmetry averaging. The gradual implementation of the successive stages of this 'Bayesian programme' should lead to an increasingly integrated, effective and dependable phasing procedure for macromolecular structure determination.

Entities:  

Year:  1993        PMID: 15299544     DOI: 10.1107/S0907444992010400

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  29 in total

1.  Complement regulation at the molecular level: the structure of decay-accelerating factor.

Authors:  P Lukacik; P Roversi; J White; D Esser; G P Smith; J Billington; P A Williams; P M Rudd; M R Wormald; D J Harvey; M D M Crispin; C M Radcliffe; R A Dwek; D J Evans; B P Morgan; R A G Smith; S M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

2.  Structure-function analysis of grass clip serine protease involved in Drosophila Toll pathway activation.

Authors:  Christine Kellenberger; Philippe Leone; Laurent Coquet; Thierry Jouenne; Jean-Marc Reichhart; Alain Roussel
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

3.  Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement.

Authors:  P D Adams; N S Pannu; R J Read; A T Brünger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Structure of a designed tetrahedral protein assembly variant engineered to have improved soluble expression.

Authors:  Jacob B Bale; Rachel U Park; Yuxi Liu; Shane Gonen; Tamir Gonen; Duilio Cascio; Neil P King; Todd O Yeates; David Baker
Journal:  Protein Sci       Date:  2015-08-06       Impact factor: 6.725

5.  How electrostatic networks modulate specificity and stability of collagen.

Authors:  Hongning Zheng; Cheng Lu; Jun Lan; Shilong Fan; Vikas Nanda; Fei Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

6.  Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Paul A Hubbard; Randall McNally; Ramachandran Murali; Basil Rapoport
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

7.  Insights into activity and inhibition from the crystal structure of human O-GlcNAcase.

Authors:  Nathaniel L Elsen; Sangita B Patel; Rachael E Ford; Dawn L Hall; Fred Hess; Hari Kandula; Maria Kornienko; John Reid; Harold Selnick; Jennifer M Shipman; Sujata Sharma; Kevin J Lumb; Stephen M Soisson; Daniel J Klein
Journal:  Nat Chem Biol       Date:  2017-03-27       Impact factor: 15.040

8.  The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.

Authors:  Liam B King; Marnie L Fusco; Andrew I Flyak; Philipp A Ilinykh; Kai Huang; Bronwyn Gunn; Robert N Kirchdoerfer; Kathryn M Hastie; Amandeep K Sangha; Jens Meiler; Galit Alter; Alexander Bukreyev; James E Crowe; Erica Ollmann Saphire
Journal:  Cell Host Microbe       Date:  2018-01-10       Impact factor: 21.023

9.  Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation.

Authors:  Stefan Svensson; Tove Ostberg; Micael Jacobsson; Carina Norström; Karin Stefansson; Dan Hallén; Isabel Climent Johansson; Kristina Zachrisson; Derek Ogg; Lena Jendeberg
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  Molecular shape and medicinal chemistry: a perspective.

Authors:  Anthony Nicholls; Georgia B McGaughey; Robert P Sheridan; Andrew C Good; Gregory Warren; Magali Mathieu; Steven W Muchmore; Scott P Brown; J Andrew Grant; James A Haigh; Neysa Nevins; Ajay N Jain; Brian Kelley
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.